NeurologyLive® Friday 5 — November 25, 2022

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Peer Exchange: Comorbidities in Patients With Multiple Sclerosis

In episode 1 of this NeurologyLive^® Peer Exchange series, "Challenges and Solutions in the Management of Multiple Sclerosis," a panel of experts in neurology discusses comorbidities in multiple sclerosis and the use of sphingosine 1-phosphate receptor modulators for treatment. [WATCH TIME: 6 minutes]

2: Insights: Insomnia Treatment Selection: DORA

In episode 8 of this NeurologyLive^® Insights series, "Management of Insomnia in Female Patients," Charlene Gamaldo, MD, discusses patient criteria for selecting a dual orexin receptor agonist (DORA) for insomnia treatment. [WATCH TIME: 3 minutes]

3: NeuroVoices: Benzi Kluger, MD, MS, on the Expansion and Growth of Neuropalliative Care

In the latest edition of our in-depth Q&A series, the president of the International Neuropalliative Care Society provided an overview of the organization’s recently concluded conference and the significance of the growth of neuropalliative care.

4: Choosing DMTs and Ongoing Debates in Multiple Sclerosis: Robert T. Naismith, MD

The professor of neurology at Washington University in St. Louis offered an overview of the State of the Science Summit that was held on November 3, 2022, featuring a panel of expert clinicians. [WATCH TIME: 3 minutes]

5: Cognition Issues in Multiple Sclerosis Are Vital to Address

In the cover story of the NeurologyLive^® November special issue, John DeLuca, PhD, offers his perspective on cognitive problems in MS, which have been reported to occur in as many as 7 in 10 individuals yet remain a difficult and undertreated challenge in clinical care.

—————————————————